CD34+ Cell Isolation from Cord Blood MNC
CD34+ cells offer valuable insights into hematopoiesis, hematological disorders, and regenerative medicine. They have potential in cancer therapies, autoimmune diseases, and genetic disorders. Isolating CD34+ cells from Cord Blood Mononuclear Cells (MNC) is crucial for research in hematopoietic stem cell biology and therapeutic advancements. MARS® Platform ensures the enrichment of CD34+ cells, enhancing purity, viability, […]
CD138+ Plasma Cell Enrichment directly from Bone Marrow
CD138 expression is a crucial marker in diagnosing plasma cell tumors and Multiple Myeloma cells. Traditionally, the evaluation of plasma cells from bone marrow involves a time-consuming and labor-intensive density gradient separation method using ficoll. However, this method leads to the loss of antigens, including CD138, from the plasma cell surface, necessitating immediate staining and […]
ASGCT 2023: Simple magnetic cell separation for both autologous and allogenic cell therapy development
INTRODUCTION Adoptive cell therapy has proven clinical efficacy in many cancer types and the success has driven more development of new drugs. However, on the manufacturing side, current process using conventional tools is complicated and results in suboptimal purity and yield sometimes. All those shortcomings may contribute to the high cost of the cell products […]
Simple magnetic cell separation enabled by an automated, closed system for both autologous and allogenic cell therapy development
INTRODUCTION Adoptive cell therapy has demonstrated effective clinical results in various types of cancer, leading to increased efforts in developing new drugs. However, the current manufacturing process using conventional tools is complex and often yields impure products, contributing to the high cost of cell therapy and limiting patient access. Both industry and academic cell therapy […]
TCR γ/δ+ separation from TCR α/ß+ with MARS® Bar
In recent years T cell receptor (TCR) cell therapy has gained popularity due to a range of possible treatments for cancer and some infectious diseases it could provide. Since γδ T-cells constitute promising effector cell compartments for cancer immunotherapy, novel γδ T-cell-based immunotherapies are being developed. Although advancements in TCR engineering, manufacturing, and clinical applications have led to […]
MARS® MAG Premium Line
MARS® MAG Premium Line is a family of cell separation reagent kits launched in collaboration with STEMCELL Technologies. These reagents have been shown to enable fast and easy isolation of many cell types, including granulocytes, NK cells, and plasma cells. With protocols optimized for the MARS instruments, the kits provide an integrated cell isolation solution. This is especially […]
MARS® Bar Platform Brochure
Download the full MARS® Bar technical specifications as a PDF Brochure.
Webinar: Applying MARS® for Pre-Enrichment of Breast Cancer Disseminated Tumor Cells in Bone Marrow
Resources / Video Webinar: Applying MARS® for Pre-Enrichment of Breast Cancer Disseminated Tumor Cells in Bone Marrow I would like to access the webinar I already have the password More to Watch: Webinar: MARS® Platform Technology overview Gentle Nuclei Isolation from Tissue Samples Gentle Nuclei Isolation from Tissue Samples Webinar: Centrifuge-Free Matrix-Free Cell Isolation found […]
MARS® Bar Technical Specifications
Download the full MARS® Bar technical specifications as a PDF Brochure.
MARS® Ingenuity™ Line of Reagents brochure
MARS® Ingenuity™ Line is a family of cell isolation reagent kits aiming to deliver combined solutions for cell therapy drug development worldwide. The kits include research and cGMP-grade reagents for fast and easy cell isolation supporting the development of CAR-T and other Cell Therapy products on the MARS® Platform. Our perfected, antigen-specific paramagnetic nanoparticles are […]